Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. - Haynes, R; Harden, P; Judge, P; Blackwell, L; Emberson, J; Landray, M; Baigent, C; Friend, P (Lancet, 2014)